Aroa Biosurgery Limited (ASX: ARX)
Australia
· Delayed Price · Currency is AUD 0.720
+0.020 (2.86%)
Dec 4, 2024, 4:10 PM AEST
Aroa Biosurgery Revenue
Aroa Biosurgery had revenue of 39.16M NZD in the half year ending September 30, 2024, with 33.47% growth. This brings the company's revenue in the last twelve months to 76.35M, up 15.87% year-over-year. In the fiscal year ending March 31, 2024, Aroa Biosurgery had annual revenue of 69.07M with 9.01% growth.
Revenue (ttm)
76.35M NZD
Revenue Growth
+15.87%
P/S Ratio
3.44
Revenue / Employee
n/a
Employees
n/a
Market Cap
241.43M AUD
Revenue Chart
* This company reports financials in NZD.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| CSL Limited | 22.18B |
| ResMed Inc. | 6.93B |
| Pro Medicus Limited | 161.50M |
| Fisher & Paykel Healthcare Corporation Limited | 1.74B |
| Cochlear Limited | 2.24B |
| Sonic Healthcare Limited | 8.97B |
| Ramsay Health Care Limited | 16.66B |
| Telix Pharmaceuticals Limited | 645.68M |
Aroa Biosurgery News
- 7 days ago - Aroa Biosurgery Ltd (ASX:ARX) H1 2025 Earnings Call Highlights: Strong Revenue Growth Amidst ... - GuruFocus